Your browser doesn't support javascript.
loading
Cilostazol but not sildenafil prevents memory impairment after chronic cerebral hypoperfusion in middle-aged rats.
Godinho, Jacqueline; de Oliveira, Janaina Nicolau; Ferreira, Emilene Dias Fiuza; Zaghi, Gislene Gonçalves D; Bacarin, Cristiano Correia; de Oliveira, Rúbia Maria Weffort; Milani, Humberto.
Afiliação
  • Godinho J; Department of Pharmacology and Therapeutics, Health Science Center, State University of Maringá, Maringá, Paraná 87020-900, Brazil.
  • de Oliveira JN; Department of Pharmacology and Therapeutics, Health Science Center, State University of Maringá, Maringá, Paraná 87020-900, Brazil.
  • Ferreira ED; Department of Pharmacology and Therapeutics, Health Science Center, State University of Maringá, Maringá, Paraná 87020-900, Brazil.
  • Zaghi GG; Department of Pharmacology and Therapeutics, Health Science Center, State University of Maringá, Maringá, Paraná 87020-900, Brazil.
  • Bacarin CC; Department of Pharmacology and Therapeutics, Health Science Center, State University of Maringá, Maringá, Paraná 87020-900, Brazil.
  • de Oliveira RM; Department of Pharmacology and Therapeutics, Health Science Center, State University of Maringá, Maringá, Paraná 87020-900, Brazil.
  • Milani H; Department of Pharmacology and Therapeutics, Health Science Center, State University of Maringá, Maringá, Paraná 87020-900, Brazil. Electronic address: hmilani@uem.br.
Behav Brain Res ; 283: 61-8, 2015 Apr 15.
Article em En | MEDLINE | ID: mdl-25623419
We previously reported that the phosphodiesterase-5 (PDE5) inhibitor sildenafil prevented neurodegeneration but not learning deficits in middle-aged rats that were subjected to the permanent, three-stage, four-vessel occlusion/internal carotid artery (4-VO/ICA) model of chronic cerebral hypoperfusion (CCH). In the present study, we examined whether the PDE3 inhibitor cilostazol alleviates the loss of long-term memory (i.e., retrograde amnesia) caused by CCH. The effect of sildenafil was then compared to cilostazol. Naive rats (12-15 months old) were trained in a non-food-rewarded eight-arm radial maze and subjected to CCH. One week later, retrograde memory was assessed for 5 weeks. Cilostazol (50mg/kg, p.o.) was administered for 42 days or 15 days, beginning approximately 45 min after the first occlusion stage. Sildenafil (3mg/kg, p.o.) was similarly administered for 15 days only. Histological examination was performed after behavioral testing. Chronic cerebral hypoperfusion caused persistent retrograde amnesia, which was reversed by cilostazol after both short-term and long-term treatment. This antiamnesic effect of cilostazol was sustained throughout the experiment, even after discontinuing treatment (15-day treatment group). This effect occurred in the absence of neuronal rescue. Sildenafil failed to prevent CCH-induced retrograde amnesia, but it reduced hippocampal cell death. Extending previous findings from this laboratory, we conclude that sildenafil does not afford memory recovery after CCH, despite its neuroprotective effect. In contrast, cilostazol abolished CCH-induced retrograde amnesia, an effect that may not depend on histological neuroprotection. The present data suggest that cilostazol but not sildenafil represents a potential strategy for the treatment of cognitive sequelae associated with CCH.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetrazóis / Isquemia Encefálica / Nootrópicos / Citrato de Sildenafila / Amnésia Retrógrada Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Behav Brain Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Brasil País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetrazóis / Isquemia Encefálica / Nootrópicos / Citrato de Sildenafila / Amnésia Retrógrada Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Behav Brain Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Brasil País de publicação: Holanda